BioSig Technologies Inc Stock Nasdaq
Equities
US09073N2018
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 1.5M | Sales 2025 * | - | Capitalization | 14.78M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -12M | EV / Sales 2024 * | 9.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.19% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 09-02-23 |
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
1st Jan change | Capi. | |
---|---|---|
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
+0.30% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |